Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: Results of the canadian open ddI treatment program
Julio S.G. Montaner, Anita Rachlis, Raymond Beaulieu, John Gill, Walter Schlech, Peter Phillips, Claude Auclair, François Boulerice, Andrew Schindzielorz, Laurie Smaldone, Mark Wainberg, Joel Singer, Martin T. Schechter
Profundice en los temas de investigación de 'Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: Results of the canadian open ddI treatment program'. En conjunto forman una huella única.